Login with ORCID

association

Full identifier: http://purl.org/np/RAfNk_vtkgfTN1wVNVBeoKLyvM9SrbwBP42b1cO0x6vYw#association

Assigned to 1 class:

Minted in Nanopublication

 RAfNk_vtkg comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAfNk_vtkg... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal)
(xsd:dateTime)
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAfNk_vtkg... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAfNk_vtkg... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAfNk_vtkg... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC...
.

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:35:57.634Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
"The use of nortriptyline hydrochloride or other tricyclic antidepressants concurrently with a monoamine oxidase (MAO) inhibitor is contraindicated. Hyperpyretic crises, severe convulsions, and fatalities have occurred when similar tricyclic antidepressants were used in such combinations. It is advisable to have discontinued the MAO inhibitor for at least two weeks before treatment with nortriptyline hydrochloride is started. Patients hypersensitive to nortriptyline hydrochloride should not be given the drug. Cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. Nortriptyline hydrochloride is contraindicated during the acute recovery period after myocardial infarction."
Leoni Bücken
2021-08-25T11:35:57.634Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:35:57.634Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:35:57.634Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:35:57.634Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:35:57.634Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:35:57.634Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)